Patricia A. Bradford

CIK: 0001313325

Transaction Breakdown

Open Market Buys (P)2 (40.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (60.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

PHIO

Phio Pharmaceuticals Corp.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

PHIO
Phio Pharmaceuticals Corp.
Sep 24, 2026
Purchase(P)
Direct
6.5K shares at avg. $1.01$7K
PHIO
Phio Pharmaceuticals Corp.
Sep 15, 2026
Purchase(P)
Direct
12K shares at avg. $1.03$12K
PHIO
Phio Pharmaceuticals Corp.
Feb 5, 2026
Award(A)
Direct
18.5K shares-
PHIO
Phio Pharmaceuticals Corp.
Sep 11, 2025
Award(A)
Direct
18.8K shares-
PHIO
Phio Pharmaceuticals Corp.
Sep 11, 2024
Award(A)
Direct
8K shares-

		Type	Shares	Price		Ownership
Sep 24, 2026	PHIO Phio Pharmaceuticals Corp.	Purchase(P)	6,500	$1.01	$6,583	Direct
Sep 15, 2026	PHIO Phio Pharmaceuticals Corp.	Purchase(P)	12,000	$1.03	$12,360	Direct
Feb 5, 2026	PHIO Phio Pharmaceuticals Corp.	Award(A)	18,500	-	$0	Direct
Sep 11, 2025	PHIO Phio Pharmaceuticals Corp.	Award(A)	18,800	-	-	Direct
Sep 11, 2024	PHIO Phio Pharmaceuticals Corp.	Award(A)	8,000	-	$0	Direct

1-5 of 5 transactions

About BRADFORD PATRICIA A

BRADFORD PATRICIA A (SEC CIK 0001313325) files insider reports with the SEC as Director of Phio Pharmaceuticals Corp. (PHIO).

Signal8 holds 5 ownership filings by BRADFORD PATRICIA A, all Form 4s, filed between Sep 12, 2024 and Sep 25, 2026. Those filings report 5 transactions, from Sep 11, 2024 to Sep 24, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on BRADFORD PATRICIA A's filings is in KING OF PRUSSIA, PA.

Recent filings by BRADFORD PATRICIA A

Sep 24, 2026: Open-market purchase of PHIO shares (Form 4, code P).
Sep 15, 2026: Open-market purchase of PHIO shares (Form 4, code P).
Feb 5, 2026: Grant or award of PHIO shares (Form 4, code A).
Sep 11, 2025: Grant or award of PHIO shares (Form 4, code A).
Sep 11, 2024: Grant or award of PHIO shares (Form 4, code A).

Other insiders filing for Phio Pharmaceuticals Corp. (PHIO)

Carson Lisa Cabott, Chief Financial Officer
Bitterman Robert J, Chairman, Pres. & CEO
Plott Ronald Todd, Director
Lockshin Curtis, Director
Freeman Jonathan E, Director
Deming David H, Director

How to read Form 4 transaction codes